AMIT KUMAR - 02 Jan 2025 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer, Director
Signature
/s/ Amit Kumar
Issuer symbol
ANIX
Transactions as of
02 Jan 2025
Transactions value $
$0
Form type
4
Filing time
03 Jan 2025, 17:40:34 UTC
Previous filing
07 Jun 2024
Next filing
15 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Award $0 +700K $0.00 700K 02 Jan 2025 Common Stock 700K $2.37 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025.